Vimarsana
Biggest News Aggregation in the World

Page 45 - Mobile Opera News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mobile Opera. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mobile Opera Today - Breaking & Trending Today

AI algorithm shows promise for early identification of geographic atrophy biomarkers - Vimarsana News

AI algorithm shows promise for early identification of geographic atrophy biomarkers

FORT LAUDERDALE, Fla. — A machine-learning algorithm showed the ability to identify spectral-domain OCT predictors of geographic atrophy in eyes with intermediate age-related macular degeneration.

Source: healio.com
Intestinal absorbent improves short-term stool consistency, abdominal pain in IBS-D - Vimarsana News

Intestinal absorbent improves short-term stool consistency, abdominal pain in IBS-D

SAN DIEGO — Enterosgel, a CE-certified intestinal absorbent, reduced short-term symptoms of stool consistency and abdominal pain among patients with irritable bowel syndrome with diarrhea, according to research. “The RELIEVE-IBS-D study was set up to investigate the efficacy and safety of Enterosgel for the treatment of irritable bowel syndrome with diarrhea. Enterosgel is a

Source: healio.com
Study dispels misconceptions of anti-reflux surgery with proof of symptom resolution - Vimarsana News

Study dispels misconceptions of anti-reflux surgery with proof of symptom resolution

SAN DIEGO — Patients who underwent laparoscopic anti-reflux surgery for gastroesophageal reflux disease experienced long-term improvement in symptoms commonly misperceived to persist, according to study results. “Our take home-message is to make patients as well as our colleagues — not only the surgeons but also the primary care physicians and gastroenterologists — who

Source: healio.com
Ustekinumab biosimilar candidate achieves 'therapeutic equivalence' - Vimarsana News

Ustekinumab biosimilar candidate achieves 'therapeutic equivalence'

AVT04, a biosimilar candidate to ustekinumab developed by Alvotech, met the primary endpoint in a confirmatory clinical study of patients with chronic plaque-type psoriasis, according to a company press.

Source: healio.com
Improving access to sleep apnea care through cardiology practice accreditation - Vimarsana News

Improving access to sleep apnea care through cardiology practice accreditation

Patients with CVD are 40% to 80% more likely to have comorbid obstructive sleep apnea, which in severe cases can cause them to stop breathing hundreds of times a night. Obstructive sleep apnea (OSA) is associated with myriad forms of CVD, including hypertension, HF, CAD, pulmonary hypertension, atrial fibrillation and stroke. Unfortunately, most cases of OSA in the U.S. are unrecognized and

Source: healio.com